Research from the University of Virginia School of Medicine has revealed crucial new insights into the immune systems of COVID-19 survivors, particularly those struggling with persistent breathing ...
Surpass-Early randomized ~800 adults with ≤4-year type 2 diabetes on metformin to add tirzepatide or intensify care, predominantly with semaglutide or dulaglutide comparators. At two years, ...
New research shows that after the body's defenses kill the virus behind COVID-19, leftover digested chunks of SARS-CoV-2 spike protein can target specific immune cells based on their shape. The ...
Global immunity developed against Covid-19 could significantly reduce the risk of future coronavirus pandemics by offering protection against other SARS-type viruses, scientists have revealed.
The most common COVID-19 symptoms doctors expect in June 2026 are a lot of what we've come to expect from the respiratory ...
Brittany Underwood was 37 when she was hit with COVID early in 2021. Her case was mild, and, like the mom she is, she took care of everyone else because of course the rest of her family had it too. It ...
Ducharme is a contributor to TIME. A health worker in Chile vaccinates someone with an AstraZeneca shot as a third booster dose against COVID-19 on Aug. 10, 2021. Ducharme is a contributor to TIME.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results